Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations (English)
- New search for: Singer, Christian F.
- New search for: Balmaña, Judith
- New search for: Bürki, Nicole
- New search for: Delaloge, Suzette
- New search for: Filieri, Maria Elisabetta
- New search for: Gerdes, Anna-Marie
- New search for: Grindedal, Eli Marie
- New search for: Han, Sileni
- New search for: Johansson, Oskar
- New search for: Kaufman, Bella
- New search for: Krajc, Mateja
- New search for: Loman, Niklas
- New search for: Olah, Edith
- New search for: Paluch-Shimon, Shani
- New search for: Plavetic, Natalija Dedic
- New search for: Pohlodek, Kamil
- New search for: Rhiem, Kerstin
- New search for: Teixeira, Manuel
- New search for: Evans, D. Gareth
- New search for: Singer, Christian F.
- New search for: Balmaña, Judith
- New search for: Bürki, Nicole
- New search for: Delaloge, Suzette
- New search for: Filieri, Maria Elisabetta
- New search for: Gerdes, Anna-Marie
- New search for: Grindedal, Eli Marie
- New search for: Han, Sileni
- New search for: Johansson, Oskar
- New search for: Kaufman, Bella
- New search for: Krajc, Mateja
- New search for: Loman, Niklas
- New search for: Olah, Edith
- New search for: Paluch-Shimon, Shani
- New search for: Plavetic, Natalija Dedic
- New search for: Pohlodek, Kamil
- New search for: Rhiem, Kerstin
- New search for: Teixeira, Manuel
- New search for: Evans, D. Gareth
In:
European journal of cancer
;
106
;
54-60
;
2019
-
ISSN:
- Article (Journal) / Print
-
Title:Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations
-
Contributors:Singer, Christian F. ( author ) / Balmaña, Judith ( author ) / Bürki, Nicole ( author ) / Delaloge, Suzette ( author ) / Filieri, Maria Elisabetta ( author ) / Gerdes, Anna-Marie ( author ) / Grindedal, Eli Marie ( author ) / Han, Sileni ( author ) / Johansson, Oskar ( author ) / Kaufman, Bella ( author )
-
Published in:European journal of cancer ; 106 ; 54-60
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2019-01-01
-
Size:7 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.994
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.994 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 106
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Evaluation of objective response, disease control and progression-free survival as surrogate end-points for overall survival in anti–programmed death-1 and anti–programmed death ligand 1 trialsNie, Run-Cong / Chen, Fo-Ping / Yuan, Shu-Qiang / Luo, Ying-Shan / Chen, Shi / Chen, Yong-Ming / Chen, Xiao-Jiang / Chen, Ying-Bo / Li, Yuan-Fang / Zhou, Zhi-Wei et al. | 2019
- 12
-
Myositis and neuromuscular side-effects induced by immune checkpoint inhibitorsMoreira, Alvaro / Loquai, Carmen / Pföhler, Claudia / Kähler, Katharina C. / Knauss, Samuel / Heppt, Markus V. / Gutzmer, Ralf / Dimitriou, Florentia / Meier, Friedegund / Mitzel-Rink, Heidrun et al. | 2019
- 24
-
Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorinHubner, Richard A. / Cubillo, Antonio / Blanc, Jean-Frédéric / Melisi, Davide / Von Hoff, Daniel D. / Wang-Gillam, Andrea / Chen, Li-Tzong / Becker, Claus / Mamlouk, Khalid / Belanger, Bruce et al. | 2019
- 34
-
Induction chemotherapy in borderline (non-)resectable pancreatic cancer: a unique window of opportunity for understanding pancreatic cancerVan Laethem, Jean-Luc et al. | 2019
- 37
-
Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysisBaraniskin, Alexander / Buchberger, Barbara / Pox, Christian / Graeven, Ulli / Holch, Julian W. / Schmiegel, Wolff / Heinemann, Volker et al. | 2019
- 45
-
European Breast Cancer Council manifesto 2018: Genetic risk prediction testing in breast cancerRutgers, Emiel / Balmana, Judith / Beishon, Marc / Benn, Karen / Evans, D. Gareth / Mansel, Robert / Pharoah, Paul / Perry Skinner, Victoria / Stoppa-Lyonnet, Dominique / Travado, Luzia et al. | 2019
- 54
-
Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendationsSinger, Christian F. / Balmaña, Judith / Bürki, Nicole / Delaloge, Suzette / Filieri, Maria Elisabetta / Gerdes, Anna-Marie / Grindedal, Eli Marie / Han, Sileni / Johansson, Oskar / Kaufman, Bella et al. | 2019
- 61
-
Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine-refractory differentiated thyroid cancerTahara, Makoto / Brose, Marcia S. / Wirth, Lori J. / Suzuki, Takuya / Miyagishi, Hideaki / Fujino, Katsuki / Dutcus, Corina E. / Gianoukakis, Andrew et al. | 2019
- 69
-
Efficacy of adjuvant chemotherapy after resection of pulmonary metastasis from colorectal cancer: a propensity score–matched analysisImanishi, Mamiko / Yamamoto, Yoshiyuki / Hamano, Yukako / Yamada, Takeshi / Moriwaki, Toshikazu / Gosho, Masahiko / Okumura, Takehiro / Boku, Narikazu / Kondo, Haruhiko / Hyodo, Ichinosuke et al. | 2019
- 78
-
TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial)Ioka, Tatsuya / Ueno, Makoto / Ueno, Hideki / Park, Joon Oh / Chang, Heung-Moon / Sasahira, Naoki / Kanai, Masashi / Chung, Ik Joo / Ikeda, Masafumi / Nakamori, Shoji et al. | 2019
- 89
-
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myelomaDimopoulos, Meletios A. / Grosicki, Sebastian / Jędrzejczak, Wiesław W. / Nahi, Hareth / Gruber, Astrid / Hansson, Markus / Gupta, Neeraj / Byrne, Catriona / Labotka, Richard / Teng, Zhaoyang et al. | 2019
- 99
-
Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysisMackay, Tara M. / van Erning, Felice N. / van der Geest, Lydia G.M. / de Groot, Jan Willem B. / Haj Mohammad, Nadia / Lemmens, Valery E. / van Laarhoven, Hanneke W. / Besselink, Marc G. / Wilmink, Johanna W. et al. | 2019
- 106
-
Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitorsde Malet, Alice / Antoni, Guillemette / Collins, Michael / Soularue, Emilie / Marthey, Lysiane / Vaysse, Thibaut / Coutzac, Clelia / Chaput, Nathalie / Mateus, Christine / Robert, Caroline et al. | 2019
- 115
-
Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)Holch, J.W. / Ricard, I. / Stintzing, S. / Fischer von Weikersthal, L. / Decker, T. / Kiani, A. / Vehling-Kaiser, U. / Heintges, T. / Kahl, C. / Kullmann, F. et al. | 2019
- 126
-
Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) reportAronson, Daniel C. / Weeda, Víola B. / Maibach, Rudolf / Czauderna, Piotr / Dall'Igna, Patrizia / de Ville de Goyet, Jean / Branchereau, Sophie / Perilongo, Giorgio / Brock, Penelope / Zsiros, Joszef et al. | 2019
- 133
-
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNAYe, Zhong / Wang, Chun / Wan, Shaogui / Mu, Zhaomei / Zhang, Zhenchao / Abu-Khalaf, Maysa M. / Fellin, Frederick M. / Silver, Daniel P. / Neupane, Manish / Jaslow, Rebecca J. et al. | 2019
- 144
-
Predictive biomarkers of response for immune checkpoint inhibitors in non–small-cell lung cancerPrelaj, Arsela / Tay, Rebecca / Ferrara, Roberto / Chaput, Nathalie / Besse, Benjamin / Califano, Raffaele et al. | 2019
- 160
-
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatmentsTavolari, S. / Deserti, M. / Vasuri, F. / Curti, S. / Palloni, A. / Pinna, A.D. / Cescon, M. / Frega, G. / De Lorenzo, S. / Barbera, M.A. et al. | 2019
- 171
-
Long-term health and social function in adult survivors of paediatric astrocytoma: A report from the Childhood Cancer Survivor StudyEffinger, Karen E. / Stratton, Kayla L. / Fisher, Paul Graham / Ness, Kirsten K. / Krull, Kevin R. / Oeffinger, Kevin C. / Armstrong, Gregory T. / Robison, Leslie L. / Hudson, Melissa M. / Leisenring, Wendy M. et al. | 2019
- 181
-
Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trialSchneeweiss, Andreas / Möbus, Volker / Tesch, Hans / Hanusch, Claus / Denkert, Carsten / Lübbe, Kristina / Huober, Jens / Klare, Peter / Kümmel, Sherko / Untch, Michael et al. | 2019
- 193
-
Presence of antibodies to striated muscle and acetylcholine receptor in association with occurrence of myasthenia gravis with myositis and myocarditis in a patient with melanoma treated with an anti–programmed death 1 antibodyShirai, T. / Kiniwa, Y. / Sato, R. / Sano, T. / Nakamura, K. / Mikoshiba, Y. / Ohashi, N. / Sekijima, Y. / Okuyama, R. et al. | 2019
- 196
-
A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncologyHaslam, Alyson / Hey, Spencer P. / Gill, Jennifer / Prasad, Vinay et al. | 2019
- 212
-
Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMTGiebel, Sebastian / Labopin, Myriam / Czerw, Tomasz / Socié, Gérard / Blaise, Didier / Ghavamzadeh, Ardeshir / Passweg, Jacob / Ljungman, Per / Poiré, Xavier / Chevallier, Patrice et al. | 2019
- 220
-
Diet-dependent toxicity of ipilimumab in metastatic melanomaMajenka, P. / Hoffmann, M. / Rötzer, I. / Dimitrakopoulou-Strauss, A. / Koschny, R. / Longerich, T. / Enk, A. / Hassel, J.C. et al. | 2019
- 225
-
Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical studyStacchiotti, S. / Simeone, N. / Lo Vullo, S. / Morosi, C. / Greco, F.G. / Gronchi, A. / Barisella, M. / Collini, P. / Zaffaroni, N. / Dagrada, G.P. et al. | 2019
- 234
-
Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumabEckstein, Markus / Erben, Philipp / Kriegmair, Maximilian C. / Worst, Thomas S. / Weiß, Cleo-Aron / Wirtz, Ralph M. / Wach, Sven / Stoehr, Robert / Sikic, Danijel / Geppert, Carol I. et al. | 2019
- 244
-
Reviewers 2018| 2019